Synthesis and Enantiomeric Separation of 2-Phthalimidino-glutaric Acid Analogues: Potent Inhibitors of Tumor Metastasis

This publication has 9 references indexed in Scilit:

• Antiangiogenic Activity of Tumor Necrosis Factor-.ALPHA. Production Regulators Derived from Thalidomide.
  Biological & Pharmaceutical Bulletin, 1999
• Inhibition of Angiogenesis by Thalidomide Requires Metabolic Activation, Which Is Species-dependent
  Biochemical Pharmacology, 1998
• Novel Biological Response Modifiers: Phthalimides with Tumor Necrosis Factor-α Production-Regulating Activity
  Journal of Medicinal Chemistry, 1997
• Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization
  Experimental Eye Research, 1997
• The effect of thalidomide on experimental tumors and metastases
  Anti-Cancer Drugs, 1996
• Embryotoxic effects of thalidomide derivatives in the non‐human primate Callithrix jacchus. IV. Teratogenicity of μg/kg doses of the EM12 enantiomers
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1994
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
  The Journal of Experimental Medicine, 1991
• Teratogen metabolism: Spontaneous decay products of thalidomide and thalidomide analogues are not bioactivated by liver microsomes
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1985
• Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
  Proceedings of the National Academy of Sciences, 1981